Antiandrogens
Aspirin
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Diet
Ensovibep
Exercise
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Proxalutamide
Quercetin
Remdesivir
Sleep
Vitamin A
Vitamin C
Vitamin D
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Antiandrogens (meta) Melatonin (meta)
Aspirin (meta) Metformin (meta)
Bamlaniv../e.. (meta) Molnupiravir (meta)
Bebtelovimab (meta) N-acetylcys.. (meta)
Bromhexine (meta) Nigella Sativa (meta)
Budesonide (meta) Nitazoxanide (meta)
Cannabidiol (meta) Nitric Oxide (meta)
Casirivimab/i.. (meta) Paxlovid (meta)
Colchicine (meta) Peg.. Lambda (meta)
Conv. Plasma (meta) Povidone-Iod.. (meta)
Curcumin (meta) Probiotics (meta)
Diet (meta) Proxalutamide (meta)
Ensitrelvir (meta) Quercetin (meta)
Ensovibep (meta) Remdesivir (meta)
Exercise (meta) Sleep (meta)
Famotidine (meta) Sotrovimab (meta)
Favipiravir (meta) Tixagev../c.. (meta)
Fluvoxamine (meta) Vitamin A (meta)
Hydroxychlor.. (meta) Vitamin C (meta)
Iota-carragee.. (meta) Vitamin D (meta)
Ivermectin (meta) Zinc (meta)
Lactoferrin (meta)

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent: 
0 0.5 1 1.5 2+ Mortality, day 45 75% Improvement Relative Risk Mortality, ICU 40% Ventilation -45% c19vitamind.com Gholi et al. Vitamin D for COVID-19 ICU PATIENTS Sufficiency Favors vitamin D Favors control
Gholi, 195 patient vitamin D ICU study: 75% lower mortality [p=0.0007] and 45% higher ventilation [p=0.27] https://c19p.org/gholi
copied to clipboard
Vitamin D deficiency is associated with increased risk of delirium and mortality among critically Ill, elderly covid-19 patients
Gholi et al., Complementary Therapies in Medicine, doi:10.1016/j.ctim.2022.102855
19 Jul 2022    Source   PDF   Share   Tweet
Prospective study of 310 COVID-19 ICU patients in Iran, showing higher mortality for patients with vitamin D deficiency.
risk of death, 74.7% lower, HR 0.25, p < 0.001, high D levels 157, low D levels 38, >30ng/mL vs. <20ng/mL, model 2, day 45.
risk of death, 39.8% lower, HR 0.60, p = 0.05, high D levels 157, low D levels 38, >30ng/mL vs. <20ng/mL, ICU mortality, model 2.
risk of mechanical ventilation, 44.9% higher, HR 1.45, p = 0.27, high D levels 157, low D levels 38, >30ng/mL vs. <20ng/mL, model 2, day 45.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Gholi et al., 7/19/2022, prospective, Iran, peer-reviewed, 4 authors.
Contact: zahra.gholi@sbmu.ac.ir, hassan.eini@gmail.com, nutritiondata@yahoo.com.
All Studies   Meta Analysis
This PaperVitamin DAll
Please send us corrections, updates, or comments. Vaccines and treatments are both valuable and complementary. All practical, effective, and safe means should be used. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases mortality, morbidity, collateral damage, and the risk of endemic status. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit